Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
Recruiting
N/A
Interventional Study
Kidney Calculi; Ureteral Calculi
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 101 (estimated)
- Sponsor
- Avvio Medical · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, with a single urinary stone in the ureter. Participants will undergo the ELS procedure and then be eval…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or Female aged \>=21 Years
* Provides written informed consent
* One urinary stone within the ureter, size \>=5 mm and \<=10 mm present on CT
* Stone is indicated for Shock Wavve Lithotrips Per AUA 2026 guidelines
* Stone to be treated has a maximum density of \<= 1200 HU…
Contacts